Abstract
In 2018, nearly 680,000 women were diagnosed globally with endometrial-, and ovarian cancer [1]. The standard of care for women with early-stage ovarian cancer (Stage IA–IIIB) is primary debulking ...
Funding Information
  • Novo Nordisk Foundation (0065353)

This publication has 54 references indexed in Scilit: